Skip to Main Content

Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327

Conditions

Diseases of the Lung | Diseases of the Respiratory Systems

Phase I

What is the purpose of this trial?

Brief Summary:

A study to evaluate Safety,Tolerability, Kinetics, and Repeatability of the Novel Lysophosphatidic Acid Receptor 1 (LPA1) Positron Emission Tomography (PET) Ligand 18F-BMS-986327.

  • Trial with
    Bristol-Myers Squibb Research and Development
  • Start Date
    09/30/2019
  • End Date
    12/30/2020
Trial Image

For more information about this study, contact:

Mark Dias

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/26/2019
  • Study HIC
    #2000026009